Neoadjuvant PD-1 Blockade in Patients with Stage IIB/C Melanoma
Clinical trial NCT03757689 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03757689
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-06
- Primary completion
- 2024-12-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.